Kpp Advisory Services LLC Gilead Sciences, Inc. Transaction History
Kpp Advisory Services LLC
- $424 Billion
- Q4 2024
A detailed history of Kpp Advisory Services LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kpp Advisory Services LLC holds 2,458 shares of GILD stock, worth $273,231. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,458
Previous 2,460
0.08%
Holding current value
$273,231
Previous $206 Million
10.08%
% of portfolio
0.05%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
987MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.8 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.97 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.71 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.44 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $139B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...